- The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer
-
Kuji S, Hirashima , Komeda S, Tanaka A, Abe M, Takahashi , Takekuma M
- KMID: 1708330
- J Gynecol Oncol.
- 2014 Apr;25(2):90-96.
- doi: 10.3802/jgo.2014.25.2.90
OBJECTIVE: The purpose of this study was to assess whether peritoneal cytology has prognostic significance in uterine cervical cancer. METHODS: Peritoneal cytology was obtained in 228 patients with carcinoma of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
-
Takekuma M, Kuji S, Tanaka A, Takahashi , Abe M, Hirashima
- KMID: 2160804
- J Gynecol Oncol.
- 2015 Jul;26(3):185-192.
- doi: 10.3802/jgo.2015.26.3.185
OBJECTIVE: The concept of platinum sensitivity and cross-resistance among platinum agents are widely known in the management of recurrent ovarian cancer. The aim of this study was to evaluate two... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality indicators for cervical cancer care in Japan
-
Watanabe T, Mikami M, Katabuchi , Kato S, Kaneuchi M, Takahashi , Nakai H, Nagase S, Niikura H, Mandai M, Hirashima , Yanai H, Yamagami W, Kamitani S, Higashi T
- KMID: 2431230
- J Gynecol Oncol.
- 2018 Nov;29(6):e83.
- doi: 10.3802/jgo.2018.29.e83
OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to... -
- CITED
-
- Close
- SHARE
-
- Close
